NASDAQ: BBLGBone Biologics Corp Earnings Dates, Reports, Calls
Bone Biologics earnings were -$3.1M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest BBLG earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$684.6k, up 2.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BBLG reported annual earnings of -$3.1M, with -57.6% growth.
BBLG earnings history
Current Revenue
$0.0
Current Earnings
-$3.1M
Current Profit Margin
0%
BBLG Return on Equity
Current Company
-59.5%
Current Industry
8.8%
Current Market
28.9%
BBLG's Return on Equity (-59.5%)... subscribe to Premium to read more.
High Return on Equity Performance
BBLG Return on Assets
Current Company
-55.7%
Current Industry
5.4%
BBLG is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when BBLG announces earnings.
BBLG Return on Capital Employed
Current Company
-57.81%
Current Industry
9.4%
BBLG's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
BBLG vs Medical Device Stocks
Bone Biologics Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.